Stay updated on Imsidolimab in Generalized Pustular Psoriasis Clinical Trial

Sign up to get notified when there's something new on the Imsidolimab in Generalized Pustular Psoriasis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Imsidolimab in Generalized Pustular Psoriasis Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The footer release/version indicator for the ClinicalTrials.gov page was updated from “Revision: v3.5.2” to “Revision: v3.5.3.” This reflects an interface/backend update rather than a change to the study record content.
    Difference
    0.1%
    Check dated 2026-04-25T18:41:15.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-18T13:33:57.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    37 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.3 to v3.5.0 on the page.
    Difference
    0.1%
    Check dated 2026-03-20T19:53:26.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    Footer revision indicator updated from Revision: v3.4.2 to Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-06T17:54:05.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Added Generalized pustular psoriasis as a condition reference and introduced a Resources section with a link to the Genetic and Rare Diseases Information Center.
    Difference
    0.2%
    Check dated 2026-02-27T18:22:46.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2. This is a routine platform update with no evident changes to the study information.
    Difference
    0.1%
    Check dated 2026-02-13T12:48:04.000Z thumbnail image

Stay in the know with updates to Imsidolimab in Generalized Pustular Psoriasis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Imsidolimab in Generalized Pustular Psoriasis Clinical Trial page.